ClinicalTrials.govpublic full text
A Study to Learn About the Safety and Immune Activity of RSVpreF in Children 2 to <18 Years of Age
respiratory syncytial virus (rsv), respiratory syncytial virus, rsv, rsv vaccine, respiratory illness, respiratory infection, pediatric, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 895750
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.